BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 12755292)

  • 21. Evaluation of variants of melanoma-associated antigen genes and mRNA transcripts in melanomas of dogs.
    Stell AJ; Dobson JM; Scase TJ; Catchpole B
    Am J Vet Res; 2009 Dec; 70(12):1512-20. PubMed ID: 19951123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients.
    Spagnoli GC; Schaefer C; Willimann TE; Kocher T; Amoroso A; Juretic A; Zuber M; Luscher U; Harder F; Heberer M
    Int J Cancer; 1995 Oct; 64(5):309-15. PubMed ID: 7591302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients.
    Bostick PJ; Morton DL; Turner RR; Huynh KT; Wang HJ; Elashoff R; Essner R; Hoon DS
    J Clin Oncol; 1999 Oct; 17(10):3238-44. PubMed ID: 10506625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can Melan-A replace S-100 and HMB-45 in the evaluation of sentinel lymph nodes from patients with malignant melanoma?
    Kucher C; Zhang PJ; Acs G; Roberts S; Xu X
    Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):324-7. PubMed ID: 16932024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of melanoma mRNA markers in sentinel nodes: pre-clinical evaluation of a single-step real-time reverse transcriptase-polymerase chain reaction assay.
    Abrahamsen HN; Nexo E; Steiniche T; Hamilton-Dutoit SJ; Sorensen BS
    J Mol Diagn; 2004 Aug; 6(3):253-9. PubMed ID: 15269303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic detection of lymph node micrometastases in patients with gastric carcinoma by multiple-marker reverse transcriptase-polymerase chain reaction assay.
    Okada Y; Fujiwara Y; Yamamoto H; Sugita Y; Yasuda T; Doki Y; Tamura S; Yano M; Shiozaki H; Matsuura N; Monden M
    Cancer; 2001 Oct; 92(8):2056-64. PubMed ID: 11596020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of melanoma micrometastases in the sentinel lymph node and in nonsentinel nodes by tyrosinase polymerase chain reaction.
    Lukowsky A; Bellmann B; Ringk A; Winter H; Audring H; Fenske S; Sterry W
    J Invest Dermatol; 1999 Oct; 113(4):554-9. PubMed ID: 10504440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time rt-PCR.
    Hilari JM; Mangas C; Xi L; Paradelo C; Ferrándiz C; Hughes SJ; Yueh C; Altomare I; Gooding WE; Godfrey TE
    Ann Surg Oncol; 2009 Jan; 16(1):177-85. PubMed ID: 18982394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma.
    Hasselmann DO; Rappl G; Rössler M; Ugurel S; Tilgen W; Reinhold U
    Oncol Rep; 2001; 8(1):115-8. PubMed ID: 11115581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.
    Okami J; Dohno K; Sakon M; Iwao K; Yamada T; Yamamoto H; Fujiwara Y; Nagano H; Umeshita K; Matsuura N; Nakamori S; Monden M
    Clin Cancer Res; 2000 Jun; 6(6):2326-32. PubMed ID: 10873083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.
    Chi DD; Merchant RE; Rand R; Conrad AJ; Garrison D; Turner R; Morton DL; Hoon DS
    Am J Pathol; 1997 Jun; 150(6):2143-52. PubMed ID: 9176405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analyses of sentinel lymph nodes: an open question.
    Bonin S; Niccolini B; Calacione R; Gambardella B; Geatti O; Stanta G; Trevisan G
    J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):34-9. PubMed ID: 11952287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
    Scoggins CR; Ross MI; Reintgen DS; Noyes RD; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Davidson BS; Sussman JJ; Edwards MJ; Martin RC; Lewis AM; Stromberg AJ; Conrad AJ; Hagendoorn L; Albrecht J; McMasters KM
    J Clin Oncol; 2006 Jun; 24(18):2849-57. PubMed ID: 16782924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of immunocytochemical techniques in canine melanoma.
    Höinghaus R; Mischke R; Hewicker-Trautwein M
    J Vet Med A Physiol Pathol Clin Med; 2002 May; 49(4):198-202. PubMed ID: 12069262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients.
    Murer K; Urosevic M; Willers J; Selvam P; Laine E; Burg G; Dummer R
    Melanoma Res; 2004 Aug; 14(4):257-62. PubMed ID: 15305155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay.
    Palmieri G; Ascierto PA; Cossu A; Mozzillo N; Motti ML; Satriano SM; Botti G; Caracò C; Celentano E; Satriano RA; Lissia A; Tanda F; Pirastu M; Castello G;
    J Clin Oncol; 2001 Mar; 19(5):1437-43. PubMed ID: 11230489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45.
    Shidham VB; Qi DY; Acker S; Kampalath B; Chang CC; George V; Komorowski R
    Am J Surg Pathol; 2001 Aug; 25(8):1039-46. PubMed ID: 11474288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloning and sequencing of canine MAGE cDNA.
    Ma Z; Khatlani TS; Ohno K; Sasaki K; Inokuma H; Onishi T
    Tissue Antigens; 2000 Aug; 56(2):166-9. PubMed ID: 11019919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution.
    Hofbauer GF; Kamarashev J; Geertsen R; Böni R; Dummer R
    Melanoma Res; 1998 Aug; 8(4):337-43. PubMed ID: 9764809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of micrometastasis in sentinel lymph nodes of patients with primary cutaneous melanoma.
    Blaheta HJ; Schittek B; Breuninger H; Garbe C
    Recent Results Cancer Res; 2001; 158():137-46. PubMed ID: 11092041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.